THE WIRE · UPDATED 5:46 PM MST No story is too small.
NewsStatewide

Scientist uses new technology to advance glaucoma research

Utah.News 1 source cited 1 primary Primary: healthcare.utah.edu Details

How this story was published

Published automatically from one public source cited; not yet reviewed by the desk. Tell us if something is wrong ↗

Primary source

healthcare.utah.edu — an official government, school or university source.

Utah.News publishes every story with the sources it was built from. Questions or a correction: corrections@utah.news.

Official source · AI-written This story comes from an official government or institutional source.
Scientist uses new technology to advance glaucoma research
Photo via University of Utah Health
Fiona McDonnell, PhD, is utilizing the iPerfusion 3 system to study fluid movement in human eye tissue to advance glaucoma research. This technology allows for real-time measurement of fluid flow in healthy and diseased tissue.

Key takeaways

  • Fiona McDonnell, PhD, is the first researcher to use the iPerfusion 3 system to study glaucoma.
  • The technology measures fluid movement through human eye tissue in real time.
  • The research is conducted at the John A. Moran Eye Center within the Alan S. Crandall Center for Glaucoma Innovation.
  • The project utilizes tissue from the Utah Lions Eye Bank and funding from The Dick and Timmy Burton Foundation.

Scientist Fiona McDonnell, PhD, is using a first-of-its-kind technology to advance glaucoma research at the John A. Moran Eye Center. According to a November 13 report, McDonnell is using the iPerfusion 3 system to measure how fluid moves through healthy and diseased human eye tissue in real time.

McDonnell, an Ireland native who joined the Moran Eye Center in 2022, is a researcher at the Alan S. Crandall Center for Glaucoma Innovation. In 2025, she became the first researcher to use the iPerfusion 3 system, a custom-designed, next-generation technology.

In a healthy eye, a thin, clear fluid nourishes the cornea and lens. This fluid is constantly produced and removed; however, in many glaucoma patients, the fluid does not drain properly. This failure causes fluid buildup and increased pressure, which can damage the optic nerve responsible for carrying visual information to the brain.

The iPerfusion 3 system uses controlled-pressure systems and sensors to pump fluid through the natural drainage pathway of eyes gifted by organ donors. This allows McDonnell to adjust pressure and resistance to observe how the drainage system functions in real time.

McDonnell can also use the device to introduce medication to observe improvements in drainage. Additionally, she can test surgical devices designed to lower eye pressure by measuring how they change fluid flow and evaluating the eye for changes after placement.

McDonnell's work with this technology began after she discussed perfusion innovation with bioengineer Joseph van Batenburg-Sherwood, PhD. She provided research insights to help develop the custom-built machine and software.

This research is supported by funding from The Dick and Timmy Burton Foundation and a partnership with the Utah Lions Eye Bank, which recovers and distributes human eye tissue for research and vision restoration. A second iPerfusion 3 unit now serves as a shared research resource at the Moran Eye Center.

McDonnell noted that human donor tissue provides information that outweighs other sources, helping to answer critical questions relevant to helping patients. The technology addresses a major biomedical challenge by allowing researchers to test how the eye functions accurately without harming patients.

Watch

Utah News

Article details

CategoryNews
ToneNeutral
ProductionAI Generated
Report a problem with this story
What's off? Pick any that fit, or just write below.

Every report is read and checked against the story's sources. Your email, if you give one, is used only to contact you about this message and is never shown publicly. Please keep other personal details out of the text. Privacy